This week ’s reading list: All the reasons the Senate-passed drug pricing bill is bad policy

Last weekend, the Senate passed theInflation Reduction Act which includes dangerous price-setting provisions. The bill now heads to the House for consideration, where it is not too late for them to stand up for patients and medical innovation by opposing the bill.
Source: The Catalyst - Category: Pharmaceuticals Tags: Research and Development Patients Government Price Setting Source Type: news